Siren LLC’s AgomAb Therapeutics NV AGMB Stock Holding History
Bought
Maintained
Sold
Other funds holding AGMB
Siren LLC's AGMB Position: Q3 2026 in Review
Siren LLC held its AgomAb Therapeutics NV (AGMB) position steady in Q3 2026 at 411,250 shares worth $4.56M. The position accounts for 0.11% of the portfolio, ranked #85.
Siren LLC first reported a position in AGMB in Q1 2026 and has held it in 3 quarters since. The position peaked at $5.34M in Q2 2026. 25 funds tracked by Wall St. Rank hold AGMB as of Q3 2026.
- Siren LLC held 411,250 shares of AgomAb Therapeutics NV worth $4.56M as of Q3 2026.
- Siren LLC left its AgomAb Therapeutics NV share count unchanged in Q3 2026.
- AgomAb Therapeutics NV made up 0.11% of Siren LLC's portfolio in Q3 2026, its #85 holding.
- Siren LLC first reported a position in AgomAb Therapeutics NV in Q1 2026 and has held it in 3 quarters since.
- Siren LLC's AgomAb Therapeutics NV position peaked at $5.34M in Q2 2026.
- 25 funds tracked by Wall St. Rank held AgomAb Therapeutics NV as of Q3 2026.
Based on Siren LLC's 13F filing for Q3 2026, filed 12 Nov 2026.